• kids leaning
  • kids run
  • kids side
  • New resources for patients at risk
  • mother kids
  • girls
  • kids food
  • kids computing
  • track
  • mother1 daughter
  • kids eating

Adrenaline for severe allergies

Anaphylaxis is a potentially life threatening, severe allergic reaction and should always be treated as a medical emergency. Adrenaline injected into the outer mid-thigh muscle is the first line treatment for anaphylaxis. Adrenaline (epinephrine) is a natural hormone released in response to stress. When injected, adrenaline rapidly reverses the effects of anaphylaxis by reducing throat swelling, opening the airways, and maintaining heart function and blood pressure.

pdfASCIA PCC Adrenaline for severe allergies 2015146.93 KB

Management of anaphylaxis

1. Identify and avoid the cause where possible.
2. Have an ASCIA Action Plan for Anaphylaxis and adrenaline autoinjector close by (easily accessible) to treat if accidental exposure occurs.

ASCIA Action Plans for Anaphylaxis (emergency response plan) must be completed by a doctor and should be kept with the adrenaline autoinjector as the plans include instructions on when and how to give an adrenaline autoinjector. Adrenaline autoinjectors contain a single, fixed dose of adrenaline, and have been designed to be given by non-medical people, such as a friend, teacher, childcare worker, parent, passer-by or by the patient themselves (if they are not too unwell to do this).

Use of adrenaline in anaphylaxis assists the body's natural response

The body's natural response to anaphylaxis is to release adrenaline, a natural "antidote" to some of the chemicals released as part of a severe allergic reaction. Therefore, injected adrenaline assists the body's natural response. As adrenaline is destroyed by enzymes in the stomach, it needs to be injected. It cannot be given by mouth, and inhaled adrenaline is ineffective. Adrenaline injected into the outer mid-thigh muscle, works rapidly to reduce throat swelling, open up the airways and maintain heart function and blood pressure. It is the only medication available for the immediate treatment of severe allergic reactions (anaphylaxis

The potential risks of NOT giving adrenaline far outweigh the potential risks of giving adrenaline

If anaphylaxis is suspected, give the adrenaline autoinjector as not giving the adrenaline autoinjector can be more harmful than giving it, even when it may not have been necessary. If in doubt, give the adrenaline autoinjector.

Common side effects of adrenaline include increased heart rate, trembling and paleness. Therefore, someone may look unwell even after the adrenaline autoinjector has been given. Of course needles may hurt, but you have to remember why you are using it and that the adrenaline can be life-saving.

Store adrenaline at room temperature

Adrenaline autoinjectors should be stored in a cool dark place at room temperature, but NOT refrigerated as this can damage the autoinjector mechanism. Whilst they should be kept out of the reach of small children, adrenaline autoinjectors must be readily available when needed and not in a locked cupboard. The shelf life of adrenaline is normally 1 or 2 years from the date of supply. You need to regularly check the expiry date on the adrenaline autoinjector.

Adrenaline should be injected into the muscle of the outer mid thigh

Adrenaline is absorbed most rapidly when injected into the outer mid-thigh muscle. Injecting into the outer mid-thigh also makes it extremely unlikely that damage to any nerves or tendons will occur, or that it will be inadvertently injected into an artery or vein. It is also the least painful part of the body to give an injection.

There are two doses of adrenaline autoinjectors available in Australia and New Zealand

Your doctor will advise which dose is required.

  • EpiPen adrenaline autoinjectors (0.3mg) are usually prescribed for children over 20kg and adults.
  • EpiPen Jr adrenaline autoinjectors (0.15mg) are usually prescribed for children weighing 10-20kg.

Each adrenaline autoinjector contains a single fixed dose of adrenaline. It is designed to be used as a first aid device by people without any medical or nursing training. Instructions for adrenaline autoinjectors are shown on the ASCIA Action Plans for Anaphylaxis that are available on the ASCIA website: www.allergy.org.au/health-professionals/anaphylaxis-resources/ascia-action-plan-for-anaphylaxis

It is important to check that you have been given the ASCIA Action Plan which matches the device you have been prescribed.

If you or your child has been prescribed an adrenaline autoinjector, it is important that you learn and practise how to use it, using a trainer device, which does not contain adrenaline. It is recommended that you practise using the trainer device at least every 3-4 months.

Further information

ASCIA anaphylaxis resources: www.allergy.org.au/health-professionals/anaphylaxis-resources

The ASCIA website (www.allergy.org.au/patients/patient-support-organisations) includes a list of patient organisation websites including:

© ASCIA 2015

The Australasian Society of Clinical Immunology and Allergy (ASCIA) is the peak professional body of clinical immunology and allergy specialists in Australia and New Zealand.

Website: www.allergy.org.au 
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 
Postal address: PO Box 450 Balgowlah, NSW Australia 2093

Disclaimer

This document has been developed and peer reviewed by ASCIA members and is based on expert opinion and the available published literature at the time of review.  Information contained in this document is not intended to replace medical advice and any questions regarding a medical diagnosis or treatment should be directed to a medical practitioner.

The development of this document is not funded by any commercial sources and is not influenced by commercial organisations.

Content last updated June 2015

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

 

Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the
HONcode standard for
trustworthy health
 information.

Verify here.

World Allergy Organization (WAO)
ASCIA is a WAO member society